Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines

Immunology

Volumn 128, Issue 3, 2009, Pages 360-368

  Park, Ga Bin ^a   Song, Hyunkeun ^a   Kim, Yeong Seok ^a   Sung, Minjung ^a   Ryu, Jeoung W ^a   Lee, Hyun Kyung ^b   Cho, Dae Ho ^c   Kim, Daejin ^d   Lee, Wang J ^e   Hur, Dae Y ^a  

^a Inje University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d Chung Ang University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Apoptosis; B cells; B7 H4; Cancer; Cell cycle; Costimulation; Epstein Barr virus

Indexed keywords

ANTIBODY; B7 ANTIGEN; B7 H4 ANTIBODY; B7 H4 ANTIGEN; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; RNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAJI CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD80; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 70349662155     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03111.x     Document Type: Article

References (35)

1. Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007 30 : 251 260.
2. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005 23 : 515 548.
3. Sica GL, Choi IH, Zhu G et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003 18 : 849 861.
4. Simon I, Liu Y, Krall KL, Urban N, Wolfert RL, Kim NW, McIntosh MW. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer. Gynecol Oncol 2007 106 : 112 118.
5. Simon I, Zhuo S, Corral L, Diamandis EP, Sarno MJ, Wolfert RL, Kim NW. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res 2006 66 : 1570 1575.
6. Tringler B, Liu W, Corral L et al. B7-H4 overexpression in ovarian tumors. Gynecol Oncol 2006 100 : 44 52.
7. Tringler B, Zhuo S, Pilkington G et al. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 2005 11 : 1842 1848.
8. Maeurer MJ, Gollin SM, Storkus WJ et al. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin Cancer Res 1996 2 : 641 652.
9. Salek-Ardakani S, Arrand JR, Mackett M. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 2002 304 : 342 351.
10. Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995 2 : 523 532.
11. Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 2002 277 : 7766 7775.
12. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004 4 : 757 768.
13. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003 3 : 801 812.
14. Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003 192 : 161 180.
15. Rickinson A. Epstein-Barr virus. Virus Res 2002 82 : 109 113.
16. Sengupta S, den Boon JA, Chen IH et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 2006 66 : 7999 8006.
17. Muller A, Schmitt L, Raftery M, Schonrich G. Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction. Eur J Immunol 1998 28 : 3488 3498.
18. Song H, Park G, Kim YS et al. B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation. Cancer Lett 2008 266 : 227 237.
19. Georgakis GV, Li Y, Rassidakis GZ, Medeiros LJ, Mills GB, Younes A. Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. Br J Haematol 2006 132 : 503 511.
20. Pene F, Claessens YE, Muller O, Viguie F, Mayeux P, Dreyfus F, Lacombe C, Bouscary D. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Oncogene 2002 21 : 6587 6597.
21. Tu Y, Gardner A, Lichtenstein A. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 2000 60 : 6763 6770.
22. Chakravarthy MV, Abraha TW, Schwartz RJ, Fiorotto ML, Booth FW. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem 2000 275 : 35942 35952.
23. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003 2 : 339 345.
24. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995 92 : 8493 8497.
25. Maddika S, Ande SR, Panigrahi S et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007 10 : 13 29.
26. Mayo LD, Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 2001 98 : 11598 11603.
27. Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 2002 277 : 5484 5489.
28. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008 27 : 5443 5453.
29. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008 14 : 159 169.
30. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999 13 : 1501 1512.
31. Kozar K, Sicinski P. Cell cycle progression without cyclin D-CDK4 and cyclin DCDK6 complexes. Cell Cycle 2005 4 : 388 391.
32. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005 24 : 2796 2809.
33. Kaldis P, Aleem E. Cell cycle sibling rivalry: Cdc2 vs Cdk2. Cell Cycle 2005 4 : 1491 1494.
34. Baker GL, Landis MW, Hinds PW. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle 2005 4 : 330 338.
35. Wikman H, Kettunen E. Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer. Expert Rev Anticancer Ther 2006 6 : 515 530.